주 메뉴 바로가기 본문으로 바로가기

전체 메뉴 사이트맵

닫기

본문 바로가기

정책동향

홈 > BT동향 > 정책동향

scrap print facebook twitter naverBand url
글 읽기

고성장 비즈니스 지원을 위한 연방연구 기술이전 및 상용화 계획 - NIH

분류 정책동향 > 정책이슈
출처 http://www.ott.nih.gov 조회 4350
자료발간일 2012-09-18 등록일 2013-06-03
첨부파일

RnD 고성장 비즈니스 지원을 위한 연방연구 기술이전...(256.466 KB)

내용바로가기
평점 평점이 없습니다.

고성장 비즈니스 지원을 위한 연방연구 기술이전 및 상용화 계획 - NIH

 

The NIH Plan for Accelerating Technology Transfer and Commercialization of Federal Research in Support of High Growth Businesses

 

Introduction


The National Institutes of Health (NIH) is the nation’s biomedical research agency. The NIH’s extramural funding supports research at more than 3,000 institutions. A portion of this funding supports the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which play a critical role in supporting the agency’s mission to improve human health. The programs are uniquely positioned to convert basic research ideas into commercially viable products and services available to the general public. The NIH intramural program includes about 6,000 scientists working at the NIH. Their output of inventions has grown over the years, resulting in the largest biomedical patent and licensing portfolio among public sector institutions worldwide. The NIH has achieved great success in licensing inventions made by the scientists who work at the NIH and the U.S. Food and Drug Administration (FDA), with 25 FDA approved products and hundreds of others having reached the market. NIH scientists have collaborated with other institutions, both for-profit and non-rofit, to leverage the scientific discoveries that ultimately benefit public health worldwide.

 

 

..........계속

 

 

▶ 박문수(Ph.D) 자료 제공

   과학기술연구개발정책 네이버카페 http://cafe.naver.com/RnD